Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy

Keyphrases

• Immunomodulatory 100%
• Indoleamine 2,3-dioxygenase 1 (IDO1) 100%
• Immune Tolerance 50%
• Dendritic Cells 50%
• Clinically Significant 25%
• Allergic Diseases 25%
• Autoimmune Disease 25%
• Regulatory T Cells 25%
• T-cell Tolerance 25%
• Cytoplasmic Enzyme 25%
• Antigen-specific T Cell Response 25%
• Chronic Infection 25%
• Promising Strategies 25%
• Chronic Inflammatory Diseases 25%
• Chronic Inflammation 25%
• Bystander Suppression 25%

Immunology and Microbiology

• Immunotherapy 100%
• Indoleamine 2,3-dioxygenase 100%
• Dendritic Cell 50%
• Immune Tolerance 50%
• T Cell 25%
• Regulatory T Cell 25%
• T-Cell Tolerance 25%
• Antigen Specificity 25%
• Inflammatory Disorder 25%